KaydedilenlerDerginizi ekleyin

Dergiler / Astım Allerji İmmünoloji / 2020 / Cilt: 18 - Sayı: 1

Successful Rapid Drug Desensitization to Ferric Carboxymaltose in Four Patients

Reyhan GÜMÜŞBURUN
Begüm GÖRGÜLÜ
Şükrü Alper AÇIKGÖZ
Ömür AYDIN
Gülfem Elif ÇELIK
Sevim BAVBEK
Sayfa
47–50
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Fifteen RDDs were successfully performed in these cases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:An iron hypersensitivity reaction can develop during infusion.
📊
Temel Bulgular & Veri:Urticaria appeared in the second hour of an IV iron sucrose infusion (ISI) performed 8 years previously in case 1 and drug provocation with IV ferric carboxymaltose was performed, but urticaria developed on the arm where the drug was administered immediately after infusing 60 cc.
💡
Sonuç & Katkı:Fifteen RDDs were successfully performed in these cases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

An iron hypersensitivity reaction can develop during infusion. Here we present four cases of Rapid Drug Desensitization (RDD) as an option for the treatment of these patients. Urticaria appeared in the second hour of an IV iron sucrose infusion (ISI) performed 8 years previously in case 1 and drug provocation with IV ferric carboxymaltose was performed, but urticaria developed on the arm where the drug was administered immediately after infusing 60 cc. Case 2 developed tongue swelling and shortness of breath within minutes of the IV ISI. Case 3 developed shortness of breath within three minutes after the first dose of IV ISI. Case 4 with iron deficiency anemia reported swelling in the throat, lips and shortness of breath after taking an unknown oral iron therapy. On the 14th day of oral ferrous sulfate therapy, the patient presented with pruritus and skin eruptions occurring 2 hours after drug ingestion. Fifteen RDDs were successfully performed in these cases.

🔖

Bu Makaleye Atıf Yap

GÜMÜŞBURUN, R., GÖRGÜLÜ, B., AÇIKGÖZ, Ş. A., AYDIN, Ö., ÇELIK, G. E., BAVBEK, S. (2020). Successful Rapid Drug Desensitization to Ferric Carboxymaltose in Four Patients. Astım Allerji İmmünoloji, Cilt: 18 - Sayı: 1, 47–50. https://ajindex.com/articles/141895

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Iron deficiency anaemia: Assessment, prevention, and control. A guide for programme managers. Geneva, World Health Organization. 2001. www.ida_prevention_assessment_control.pdf Accessed26March2015
  2. Wang C, Graham DJ, Kane RC, Xie D, Wernecke M, Levenson M, et al. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 2015;314(19):2062-8
  3. Castells MC, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI, et al. Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008;122:574-80
  4. Bircher AJ, Auerbach M. Hypersensitivity from intravenous iron products. Immunol Allergy Clin North Am 2014;34(3): 707-23
  5. Morales Mateluna CA, Scherer Hofmeier K, Bircher AJ. Approach to hypersensitivity reactions from intravenous iron preparations. Allergy 2017;72:827–30
  6. Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, et al. Hypersensitivity reactions to intravenous iron: Guidance for risk minimization and management. Haematologica 2014;99(11):1671-6
  7. Altman LC, Petersen PE. Successful prevention of an anaphylactoid reaction to iron dextran. Ann Intern Med 1988;109(4):346-7
  8. Monaghan MS, Glasco G, St John G, Bradsher RW, Olsen KM. Safe administration of iron dextran to a patient who reacted to the test dose. South Med J 1994;87(10):1010-2
  9. Rodriguez-Jimenez B, Dominguez-Ortega J, Nunez-Acevedo B, Cava-Sumner B, Kindelan-Recarte C, Montojo-Guillen C. Rapid iron desensitization after generalized urticaria and facial angioedema. J Investig Allergol Clin Immunol 2014;24(1):56-71
  10. Montandon SV, Fajt ML, Petrov AA. A safe and novel desensitization protocol with ferric carboxymaltose to treat iron deficiency anemia. Curr Drug Saf 2016;11(2):145-8.